subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: spinal stenosis


subject: UNII:7EC9WBC6KF

subject_name: IOPOFOSINE

object_name: Childhood Glioblastoma

tested_intervention: unsure


subject: UNII:7EC9WBC6KF

object_name: adult glioblastoma


subject: UMLS:C1701188


subject: UMLS:C1701188


subject: PUBCHEM.COMPOUND:3033637

subject_name: nizatidine

object_name: gastritis

tested_intervention: yes


subject: PUBCHEM.COMPOUND:3033637

object_name: Gastritis, CTCAE


subject: CHEBI:42797

subject_name: Gabapentin

object_name: mucositis


subject: CHEBI:42797

object_name: radiation-induced disorder


subject: CHEBI:234073

subject_name: Fenebrutinib

object_name: primary progressive multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL2108632

subject_name: PLATELETS

object_name: fetal and neonatal alloimmune thrombocytopenia


subject: CHEMBL.COMPOUND:CHEMBL2108632

object_name: neonatal thrombocytopenia


subject: CHEMBL.COMPOUND:CHEMBL2108632

object_name: Intraventricular hemorrhage


subject: UMLS:C0443116

subject_name: Platelets Product


subject: UMLS:C0443116


subject: UMLS:C0443116


subject: CHEBI:291342

subject_name: Desloratadine

object_name: common cold


subject: CHEBI:291342

object_name: Upper Respiratory Infections


subject: CHEBI:291342

object_name: chronic obstructive pulmonary disease


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C4725946

subject_name: Panobinostat Nanoparticle Formulation MTX110

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C4725946

object_name: Recurrent Glioblastoma


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: epilepsy


subject: CHEBI:144475

subject_name: Ser-Leu-Ser

object_name: heart failure


subject: CHEBI:144475

object_name: congestive heart failure


subject: CHEBI:45599

subject_name: Dodecyl sulfate


subject: CHEBI:45599


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage II Grade 2 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage II Grade 1 Follicular Lymphoma


subject: UNII:O43472U9X8

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2109435

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2109435

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109435

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Transsexual (finding)


subject: CHEBI:63717

object_name: Transgender


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427

object_name: HIV infection


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: Stress urinary incontinence


subject: PUBCHEM.COMPOUND:6012

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:6012

object_name: Menopause


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: myeloproliferative neoplasm


subject: UMLS:C2367757

subject_name: human papilloma virus vaccine, bivalent

object_name: Verruca viral


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant


subject: UMLS:C2981819

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C2981819

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2981819

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2981819

object_name: Nasopharyngeal cancer recurrent


subject: UMLS:C2981819

object_name: FGFR2 Gene Amplification


subject: UMLS:C2981819

object_name: FGFR1 Gene Amplification


subject: UMLS:C2981819

object_name: FGFR Gene Amplification


subject: UMLS:C2981819

object_name: FGFR3 gene mutation


subject: UMLS:C2981819

object_name: human papilloma virus infection


subject: CHEBI:63451

subject_name: Infigratinib


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:63451


subject: CHEBI:48828

object_name: HIV-1 infection


subject: GTOPDB:9531

subject_name: CO


subject: CHEBI:27638

subject_name: Cobalt


subject: CHEBI:17245

subject_name: Carbon monoxide


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: nicotine dependence


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Alzheimer disease


subject: UMLS:C5690480

object_name: endogenous depression


subject: UMLS:C5690480

object_name: major depressive disorder


subject: UMLS:C3529783

object_name: sciatica


subject: UMLS:C3529783

object_name: complex regional pain syndrome


subject: UNII:IJ5CEP760Y

object_name: non-Hodgkin lymphoma


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: pancreatic neoplasm


subject: CHEBI:63637

object_name: exocrine pancreatic carcinoma


subject: CHEBI:63637

object_name: malignant pancreatic neoplasm


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Childhood Solid Neoplasm


subject: UNII:TWF0ML1CK8

object_name: Adult Solid Neoplasm


subject: UNII:TWF0ML1CK8

object_name: Solid Neoplasm


subject: UNII:WJY2LV4368

object_name: inflammatory bowel disease


subject: UMLS:C0687700

subject_name: CCNU

object_name: glioma


subject: UMLS:C0687700

object_name: malignant glioma


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:100246

subject_name: Norfloxacin

object_name: Primary bacterial peritonitis


subject: CHEBI:100246

object_name: acute spontaneous bacterial peritonitis


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: adult acute myeloid leukemia with del(5q)


subject: UNII:M89N0Q7EQR

object_name: Blast Phase


subject: UNII:M89N0Q7EQR

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: leukemia, myeloid, accelerated-phase


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: chronic kidney disease


subject: UMLS:C0085297

object_name: Chronic uremia


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Early Stage Breast Carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Obstruction


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: acute myeloid leukemia


subject: UMLS:C0962969

subject_name: RAD 001


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: hepatitis C


subject: CHEBI:10782

subject_name: Perilla alcohol

object_name: glioblastoma


subject: CHEBI:10782

object_name: Brain Stem Glioblastoma


subject: CHEBI:10782

object_name: glioma susceptibility 1


subject: CHEBI:145806

subject_name: (R)-(+)-perillyl alcohol


subject: CHEBI:145806


subject: CHEBI:145806


subject: CHEBI:15420

subject_name: perillyl alcohol


subject: CHEBI:15420


subject: CHEBI:15420


subject: DRUGBANK:DB10631

subject_name: Cranberry

object_name: bacterial urinary tract infection


subject: DRUGBANK:DB10631

object_name: Urinary Tract Infection, CTCAE


subject: UMLS:C0453273

subject_name: cranberry preparation


subject: UMLS:C0453273


subject: UMLS:C0950801

object_name: glaucoma


subject: UMLS:C0950801

object_name: Glaucoma, CTCAE


subject: CHEBI:134738

subject_name: Laquinimod

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:197437

object_name: head and neck squamous cell carcinoma


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: Klatskin Tumor


subject: UMLS:C0723595

subject_name: Tace


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Liver transplant rejection


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C0718234

subject_name: Acthar

object_name: membranous glomerulonephritis


subject: CHEBI:9144

subject_name: Silibinin

object_name: tuberculosis


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:173081

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride


subject: UMLS:C4528197


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:9150

subject_name: Simvastatin

object_name: non-small cell lung carcinoma


subject: UMLS:C5226760

object_name: myocardial infarction


subject: UMLS:C5226760

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C5226760

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: cardiac arrest


subject: CHEBI:9130

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:9674

subject_name: Triazolam

object_name: anxiety


subject: CHEBI:9674

object_name: Anxiety symptoms


subject: CHEBI:9674

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:9674

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:94366

subject_name: itraconazole

object_name: chronic rhinosinusitis


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: diabetic kidney disease


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: DNA repair disease


subject: UNII:52CMI0WC3Y

object_name: Lynch syndrome


subject: UNII:52CMI0WC3Y

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: UMLS:C3827082

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: familial pityriasis rubra pilaris


subject: PUBCHEM.COMPOUND:138713709

object_name: pityriasis rubra pilaris


subject: UMLS:C0796638

subject_name: Lurtotecan Liposome

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:LNU830UGAX

subject_name: AFIMKIBART

object_name: rheumatoid arthritis


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: Postoperative delirium


subject: CHEBI:135765

object_name: Emergence Delirium


subject: CHEBI:135765

object_name: post-operative delirium


subject: CHEBI:135765

object_name: Physiological Stress


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEMBL.COMPOUND:CHEMBL3707359

subject_name: DAXIBOTULINUMTOXINA

object_name: Spastic Dysphonia


subject: CHEMBL.COMPOUND:CHEMBL3707359

object_name: Dysphonia


subject: CHEMBL.COMPOUND:CHEMBL3707359

object_name: Adductor spastic dysphonia


subject: CHEMBL.COMPOUND:CHEMBL3707359

object_name: voice disorders


subject: UMLS:C5240001

subject_name: Vaccine product containing only Measles morbillivirus antigen (medicinal product)

object_name: Japanese encephalitis


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate


subject: CHEBI:73616

subject_name: Met-Val


subject: UMLS:C4683045

subject_name: Botanical Extract DCB-BO1301

object_name: Advanced Melanoma


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Rett syndrome


subject: UMLS:C0388088


subject: UMLS:C2703101

subject_name: TRC102 Base

object_name: childhood neoplasm


subject: UMLS:C2703101

object_name: neoplastic syndrome


subject: UMLS:C2703101

object_name: cancer or benign tumor


subject: UMLS:C2703101

object_name: neoplasm


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:3095

subject_name: Biguanide

object_name: acute liver failure


subject: CHEBI:3095

object_name: liver carcinoma


subject: CHEBI:3095

object_name: Cirrhosis


subject: CHEBI:3095

object_name: liver cirrhosis


subject: UMLS:C0062525

subject_name: Hyperhep B


subject: UMLS:C0062525


subject: UMLS:C0062525


subject: UMLS:C0062525


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:2469

subject_name: Adefovir


subject: CHEBI:2469


subject: CHEBI:2469


subject: CHEBI:27732

subject_name: Caffeine

object_name: myocardial infarction


subject: CHEBI:27732

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:27732

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:30742

subject_name: macrogol

object_name: Chronic functional constipation


subject: CHEBI:3636

subject_name: Chloroprocaine

object_name: cesarean section; complications


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: ventilator-associated pneumonia


subject: PUBCHEM.COMPOUND:122173807

object_name: Upper Respiratory Infections


subject: PUBCHEM.COMPOUND:122173807

object_name: respiratory tract infectious disorder


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: chronic hepatitis B virus infection


subject: UMLS:C3641122


subject: DRUGBANK:DB19014

subject_name: Imdusiran


subject: UNII:43Y934BBZ6

object_name: acute myeloid leukemia by FAB classification


subject: UNII:43Y934BBZ6

object_name: acute myeloid leukemia


subject: UNII:43Y934BBZ6

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: KRAS mutation-related tumors


subject: CHEBI:15968

subject_name: Ompenaclid

object_name: colorectal cancer


subject: CHEBI:15968

object_name: colorectal carcinoma


subject: CHEBI:15968

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:15968

object_name: digestive system cancer


subject: CHEBI:15968

object_name: metastatic colorectal cancer


subject: CHEBI:15968

object_name: digestive system neoplasm


subject: CHEBI:15968

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:15968

object_name: colorectal neoplasm


subject: CHEBI:15968

object_name: Stomach cancer


subject: CHEBI:15968

object_name: gastric cancer


subject: CHEBI:15968


subject: CHEBI:15968

object_name: gastric neoplasm


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: Retinal angiomatous proliferation


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: bladder tumor


subject: CHEBI:6427

subject_name: Leuprolide

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: uterine sarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Adult Classical Hodgkin Lymphoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C2826078

subject_name: Coagadex

object_name: acquired factor X deficiency


subject: UNII:01925N33BL

object_name: malaria


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: PUBCHEM.COMPOUND:23627211

object_name: Alzheimer disease


subject: UMLS:C4305834


subject: UMLS:C0358949

subject_name: Diprosalic ointment

object_name: psoriasis vulgaris


subject: UMLS:C0360567

subject_name: Elocon ointment


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: bronchopulmonary dysplasia


subject: UMLS:C3485429

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: diffuse cutaneous systemic sclerosis


subject: CHEBI:168396

object_name: diffuse scleroderma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:6704

subject_name: Mebendazole

object_name: medulloblastoma


subject: CHEBI:6704

object_name: childhood medulloblastoma


subject: CHEBI:6704

object_name: adult medulloblastoma


subject: CHEBI:6704

object_name: Childhood Glioblastoma


subject: CHEBI:6704

object_name: adult glioblastoma


subject: CHEBI:6704

object_name: Oligodendroblastoma


subject: CHEBI:6704

object_name: malignant glioma


subject: CHEBI:6704

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:6704

object_name: anaplastic oligodendroglioma


subject: CHEBI:6704

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Relapsing acute myeloid leukemia


subject: PUBCHEM.COMPOUND:23400030

subject_name: Trodusquemine

object_name: diabetes mellitus


subject: UMLS:C1099662


subject: UMLS:C1099662

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1099662

object_name: obesity


subject: UMLS:C1099662

object_name: Obesity, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: acute myocardial infarction


subject: CHEBI:6801

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:6801

object_name: ST-elevation myocardial infarction


subject: CHEBI:6801

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:6801

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Stage III Childhood Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: GTOPDB:9209

subject_name: zolbetuximab

object_name: Stomach cancer


subject: GTOPDB:9209

object_name: gastric cancer


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: UNII:L7451S9126

subject_name: Crizanlizumab

object_name: priapism


subject: CHEBI:125482

subject_name: Nitroaspirin

object_name: type 2 diabetes mellitus


subject: CHEBI:94534

subject_name: olanzapine

object_name: bipolar I disorder


subject: PUBCHEM.COMPOUND:544190

object_name: metabolic disease


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UNII:70FJN2AW22

object_name: metastatic prostate carcinoma


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680


subject: CHEBI:91083

subject_name: Romiplostim

object_name: Childhood Solid Neoplasm


subject: CHEBI:91083

object_name: Adult Solid Neoplasm


subject: CHEBI:91083

object_name: Solid Neoplasm


subject: CHEBI:91083

object_name: Solid carcinoma


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C4330473

subject_name: Idronoxil Suppository NOX66

object_name: cancer


subject: UMLS:C4330473

object_name: neoplasm


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: mild neurocognitive disorder


subject: CHEBI:79033

object_name: mild cognitive impairment


subject: UMLS:C1706844


subject: CHEBI:17941

subject_name: Isoflurophate

object_name: sickle cell disease


subject: PR:000022309

subject_name: coenzyme A biosynthesis bifunctional protein CoaBC


subject: UMLS:C0971122

subject_name: ICL 670A

object_name: Cooley's anemia


subject: CHEBI:49005

subject_name: Deferasirox


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Unspecified antibiotic causing adverse effects in therapeutic use


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:6121

subject_name: Ketamine

object_name: Burn injury


subject: CHEBI:6121

object_name: Burn, CTCAE


subject: CHEBI:6121

object_name: Dissociation


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: myoclonic epilepsy


subject: CHEBI:65353

object_name: Drug Resistant Epilepsy


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Asthmatic pulmonary eosinophilia


subject: UNII:420K487FSG

object_name: Eosinophilic disorder


subject: UNII:420K487FSG

object_name: Eosinophilia


subject: UNII:420K487FSG

object_name: Eosinophilia, CTCAE


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C4473918

subject_name: bovine lipid extract surfactant


subject: UMLS:C4473918

object_name: acute respiratory distress syndrome


subject: CHEBI:30742

subject_name: macrogol

object_name: Bedwetting


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: gastric mucosa-associated lymphoid tissue lymphoma


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: neuralgia


subject: CHEMBL.COMPOUND:CHEMBL2108465

object_name: Neuropathic pain


subject: CHEMBL.COMPOUND:CHEMBL2108465

object_name: sciatic nerve pain


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: UNII:C5529G5JPQ


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Interstitial lung fibrosis


subject: CHEBI:63115

object_name: failure; transplant, kidney


subject: CHEBI:63115

object_name: Kidney transplant failure and rejection


subject: CHEBI:63115

object_name: Renal transplant rejection


subject: CHEBI:63115

object_name: Disorder of transplanted kidney


subject: CHEBI:63115

object_name: chronic kidney disease


subject: CHEBI:63115

object_name: Chronic uremia


subject: CHEBI:63115

object_name: Graft Rejection


subject: UNII:TA3QN7788D

object_name: plasma cell myeloma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Acute coagulopathy


subject: CHEBI:58007

object_name: Surgical Wound Infection


subject: CHEBI:58007

object_name: colorectal cancer


subject: CHEBI:58007

object_name: colorectal carcinoma


subject: CHEBI:58007

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:17076

subject_name: Streptomycin


subject: CHEBI:17076


subject: CHEBI:17076


subject: CHEBI:17076


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: psoriatic arthritis


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: pediatric lymphoma


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:92043599

object_name: traumatic brain injury


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541


subject: UMLS:C1170584

subject_name: Restasis

object_name: Trachyonychia


subject: UMLS:C1170584

object_name: Fragile nails


subject: UMLS:C1170584

object_name: Brittle nails


subject: UMLS:C2699534

subject_name: Cyclosporine Ophthalmic Emulsion


subject: UMLS:C2699534


subject: UMLS:C2699534


subject: PUBCHEM.COMPOUND:4087

object_name: hypotension


subject: PUBCHEM.COMPOUND:4087

object_name: Hypotension, CTCAE


subject: CHEBI:6794

subject_name: Metaraminol


subject: CHEBI:6794


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: systemic sclerosis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:3766

subject_name: Clozapine

object_name: Parkinson disease


subject: UNII:Y21YS63R90

subject_name: ANNEXIN A5

object_name: retinal vein occlusion


subject: CHEBI:74705

subject_name: Met-Leu

object_name: malignant peritoneal mesothelioma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: GTOPDB:13624

subject_name: inclisiran


subject: CHEBI:144551

subject_name: Oxybutynin

object_name: blood coagulation disease


subject: CHEBI:23965

subject_name: estradiol

object_name: Transsexualism


subject: CHEBI:23965


subject: UMLS:C5667039

subject_name: Leuprolide Acetate for Injectable Suspension TOL2506

object_name: Childhood Breast Carcinoma


subject: UMLS:C5667039

object_name: breast carcinoma


subject: UMLS:C5667039

object_name: breast cancer


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:45716

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:45716

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:45716

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: MESH:C466383

subject_name: Prempro

object_name: epilepsy


subject: MESH:C466383

object_name: Menopause present (finding)


subject: MESH:C466383

object_name: Menopause


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Frontal balding


subject: CHEBI:39867

subject_name: Valproic acid


subject: HMDB:HMDB0255819

subject_name: Nusinersen

object_name: spinal muscular atrophy, type 1


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: acute diarrhea


subject: CHEBI:35176

object_name: diarrhea 9


subject: CHEBI:35176

object_name: infantile diarrhea


subject: UNII:6897GXD6OE

object_name: aortic aneurysm


subject: UNII:6897GXD6OE

object_name: Aortic aneurysm without mention of rupture NOS


subject: UNII:6897GXD6OE

object_name: Metastatic malignant neoplasm to liver


subject: UNII:6897GXD6OE

object_name: liver cancer


subject: UNII:6897GXD6OE

object_name: liver neoplasm


subject: UNII:6897GXD6OE

object_name: Adult Liver Carcinoma


subject: UNII:6897GXD6OE

object_name: liver carcinoma


subject: CHEBI:232799

subject_name: insulin lispro

object_name: dry eye syndrome


subject: CHEBI:232799

object_name: Dry Eye, CTCAE


subject: CHEBI:232799

object_name: Dryness of eye


subject: CHEBI:232799

object_name: Sicca Syndrome


subject: CHEBI:5931

subject_name: insulin human


subject: UNII:4N9P6CC1DX

subject_name: Echinacea

object_name: HIV infection


subject: UMLS:C5445960

subject_name: Echinacea antigen


subject: GTOPDB:10140

subject_name: spartalizumab

object_name: triple-negative breast carcinoma


subject: GTOPDB:10140

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:10140

object_name: Microsatellite instability-high colorectal cancer


subject: GTOPDB:10140

object_name: small cell lung carcinoma


subject: GTOPDB:10140

object_name: ovarian carcinoma


subject: GTOPDB:10140

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:10140

object_name: HER2 positive breast carcinoma


subject: GTOPDB:10140

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:10140

object_name: cancer of unknown primary site


subject: GTOPDB:10140

object_name: squamous cell lung carcinoma


subject: GTOPDB:10140

object_name: clear cell renal carcinoma


subject: GTOPDB:10140

object_name: prostate adenocarcinoma


subject: GTOPDB:10140

object_name: colorectal adenocarcinoma


subject: GTOPDB:10140

object_name: pancreatic adenocarcinoma


subject: GTOPDB:10140

object_name: esophageal adenocarcinoma


subject: GTOPDB:10140

object_name: carcinosarcoma of the corpus uteri


subject: GTOPDB:10140

object_name: uterine carcinosarcoma


subject: GTOPDB:10140

object_name: liver carcinoma


subject: GTOPDB:10140

object_name: urothelial carcinoma


subject: GTOPDB:10140

object_name: transitional cell carcinoma


subject: GTOPDB:10140

object_name: endometrium adenocarcinoma


subject: GTOPDB:10140

object_name: gastric adenocarcinoma


subject: GTOPDB:10140

object_name: lung adenocarcinoma


subject: GTOPDB:10140

object_name: cholangiocarcinoma


subject: GTOPDB:10140

object_name: suppressor of tumorigenicity 3


subject: GTOPDB:10140

object_name: cervical carcinoma


subject: GTOPDB:10140

object_name: thyroid gland carcinoma


subject: GTOPDB:10140

object_name: Mesothelioma


subject: GTOPDB:10140

object_name: mesothelial neoplasm


subject: GTOPDB:10140

object_name: malignant mesothelioma


subject: GTOPDB:10140

object_name: anal margin carcinoma


subject: GTOPDB:10140

object_name: anal carcinoma


subject: GTOPDB:10140

object_name: uveal melanoma


subject: GTOPDB:10140

object_name: melanoma


subject: GTOPDB:10140

object_name: malignant soft tissue neoplasm


subject: GTOPDB:10140

object_name: sarcoma


subject: UNII:QOG25L6Z8Z

object_name: triple-negative breast carcinoma


subject: UNII:QOG25L6Z8Z

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:QOG25L6Z8Z

object_name: Microsatellite instability-high colorectal cancer


subject: UNII:QOG25L6Z8Z

object_name: small cell lung carcinoma


subject: UNII:QOG25L6Z8Z

object_name: ovarian carcinoma


subject: UNII:QOG25L6Z8Z

object_name: malignant epithelial tumor of ovary


subject: UNII:QOG25L6Z8Z

object_name: HER2 positive breast carcinoma


subject: UNII:QOG25L6Z8Z

object_name: head and neck squamous cell carcinoma


subject: UNII:QOG25L6Z8Z

object_name: cancer of unknown primary site


subject: UNII:QOG25L6Z8Z

object_name: squamous cell lung carcinoma


subject: UNII:QOG25L6Z8Z

object_name: clear cell renal carcinoma


subject: UNII:QOG25L6Z8Z

object_name: prostate adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: colorectal adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: pancreatic adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: esophageal adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: carcinosarcoma of the corpus uteri


subject: UNII:QOG25L6Z8Z

object_name: uterine carcinosarcoma


subject: UNII:QOG25L6Z8Z

object_name: liver carcinoma


subject: UNII:QOG25L6Z8Z

object_name: urothelial carcinoma


subject: UNII:QOG25L6Z8Z

object_name: transitional cell carcinoma


subject: UNII:QOG25L6Z8Z

object_name: endometrium adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: gastric adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: lung adenocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: cholangiocarcinoma


subject: UNII:QOG25L6Z8Z

object_name: suppressor of tumorigenicity 3


subject: UNII:QOG25L6Z8Z

object_name: cervical carcinoma


subject: UNII:QOG25L6Z8Z

object_name: thyroid gland carcinoma


subject: UNII:QOG25L6Z8Z

object_name: Mesothelioma


subject: UNII:QOG25L6Z8Z

object_name: mesothelial neoplasm


subject: UNII:QOG25L6Z8Z

object_name: malignant mesothelioma


subject: UNII:QOG25L6Z8Z

object_name: anal margin carcinoma


subject: UNII:QOG25L6Z8Z

object_name: anal carcinoma


subject: UNII:QOG25L6Z8Z

object_name: uveal melanoma


subject: UNII:QOG25L6Z8Z

object_name: melanoma


subject: UNII:QOG25L6Z8Z

object_name: malignant soft tissue neoplasm


subject: UNII:QOG25L6Z8Z

object_name: sarcoma


subject: UMLS:C4053607

object_name: Microsatellite instability-high colorectal cancer


subject: UMLS:C4053607

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4053607

object_name: HER2 positive breast carcinoma


subject: UMLS:C4053607

object_name: cancer of unknown primary site


subject: UMLS:C4053607

object_name: clear cell renal carcinoma


subject: UMLS:C4053607

object_name: prostate adenocarcinoma


subject: UMLS:C4053607

object_name: colorectal adenocarcinoma


subject: UMLS:C4053607

object_name: pancreatic adenocarcinoma


subject: UMLS:C4053607

object_name: carcinosarcoma of the corpus uteri


subject: UMLS:C4053607

object_name: uterine carcinosarcoma


subject: UMLS:C4053607

object_name: urothelial carcinoma


subject: UMLS:C4053607

object_name: transitional cell carcinoma


subject: UMLS:C4053607

object_name: endometrium adenocarcinoma


subject: UMLS:C4053607

object_name: lung adenocarcinoma


subject: UMLS:C4053607

object_name: cholangiocarcinoma


subject: UMLS:C4053607

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4053607

object_name: cervical carcinoma


subject: UMLS:C4053607

object_name: thyroid gland carcinoma


subject: UMLS:C4053607

object_name: Mesothelioma


subject: UMLS:C4053607

object_name: mesothelial neoplasm


subject: UMLS:C4053607

object_name: malignant mesothelioma


subject: UMLS:C4053607

object_name: anal margin carcinoma


subject: UMLS:C4053607

object_name: anal carcinoma


subject: UMLS:C4053607

object_name: uveal melanoma


subject: UMLS:C4053607

object_name: malignant soft tissue neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: ovarian carcinoma


subject: GTOPDB:9592

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:9592

object_name: HER2 positive breast carcinoma


subject: GTOPDB:9592

object_name: cancer of unknown primary site


subject: GTOPDB:9592

object_name: squamous cell lung carcinoma


subject: GTOPDB:9592

object_name: prostate adenocarcinoma


subject: GTOPDB:9592

object_name: colorectal adenocarcinoma


subject: GTOPDB:9592

object_name: pancreatic adenocarcinoma


subject: GTOPDB:9592

object_name: carcinosarcoma of the corpus uteri


subject: GTOPDB:9592

object_name: uterine carcinosarcoma


subject: GTOPDB:9592

object_name: endometrium adenocarcinoma


subject: GTOPDB:9592

object_name: suppressor of tumorigenicity 3


subject: GTOPDB:9592

object_name: thyroid gland carcinoma


subject: GTOPDB:9592

object_name: Mesothelioma


subject: GTOPDB:9592

object_name: mesothelial neoplasm


subject: GTOPDB:9592

object_name: malignant mesothelioma


subject: GTOPDB:9592

object_name: anal carcinoma


subject: GTOPDB:9592

object_name: uveal melanoma


subject: GTOPDB:9592

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: HER2 positive breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: cancer of unknown primary site


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: squamous cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: prostate adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: colorectal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: pancreatic adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: carcinosarcoma of the corpus uteri


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: uterine carcinosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: endometrium adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: suppressor of tumorigenicity 3


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: thyroid gland carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: Mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: mesothelial neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: malignant mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: anal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: uveal melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

object_name: malignant soft tissue neoplasm


subject: UMLS:C4053664

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4053664

object_name: HER2 positive breast carcinoma


subject: UMLS:C4053664

object_name: cancer of unknown primary site


subject: UMLS:C4053664

object_name: squamous cell lung carcinoma


subject: UMLS:C4053664

object_name: prostate adenocarcinoma


subject: UMLS:C4053664

object_name: colorectal adenocarcinoma


subject: UMLS:C4053664

object_name: pancreatic adenocarcinoma


subject: UMLS:C4053664

object_name: carcinosarcoma of the corpus uteri


subject: UMLS:C4053664

object_name: uterine carcinosarcoma


subject: UMLS:C4053664

object_name: endometrium adenocarcinoma


subject: UMLS:C4053664

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4053664

object_name: thyroid gland carcinoma


subject: UMLS:C4053664

object_name: Mesothelioma


subject: UMLS:C4053664

object_name: mesothelial neoplasm


subject: UMLS:C4053664

object_name: malignant mesothelioma


subject: UMLS:C4053664

object_name: anal carcinoma


subject: UMLS:C4053664

object_name: uveal melanoma


subject: UMLS:C4053664

object_name: malignant soft tissue neoplasm


subject: UNII:8F63U28T2V

subject_name: Imexon

object_name: non-small cell lung carcinoma


subject: UNII:8F63U28T2V

object_name: Childhood Breast Carcinoma


subject: UNII:8F63U28T2V

object_name: breast carcinoma


subject: UNII:8F63U28T2V

object_name: breast cancer


subject: UNII:8F63U28T2V

object_name: prostate carcinoma


subject: UNII:8F63U28T2V

object_name: prostate cancer


subject: CHEBI:15940

subject_name: Niacin

object_name: hypoalphalipoproteinemia


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: Ewing sarcoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C3896806


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: myotonic dystrophy type 2


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8


subject: CHEBI:31348

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:74073

subject_name: Ile-Met


subject: CHEBI:74073


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEBI:30366


subject: CHEBI:141441

subject_name: Ile-Thr


subject: CHEBI:141441


subject: CHEBI:70839

subject_name: Dasatinib

object_name: prostate neoplasm


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: cytokine release syndrome


subject: CHEBI:201431

object_name: Cytokine Release Syndrome, CTCAE


subject: CHEBI:201431

object_name: complications of organ transplant stem cells


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: sarcopenia


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C1250042


subject: UNII:IK8S1P79MU

subject_name: arginine butyrate

object_name: lymphoproliferative syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297982

subject_name: ARGININE BUTYRATE


subject: UMLS:C0052329


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:31689

subject_name: Iguratimod

object_name: Sicca Syndrome


subject: CHEBI:31689

object_name: Primary Sjögren's syndrome


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pulmonary eosinophilia


subject: CHEBI:73604

object_name: eosinophilic pneumonia


subject: CHEBI:73604

object_name: chronic disease


subject: CHEBI:73604

object_name: Chronic Disease


subject: CHEBI:119915

subject_name: Fentanyl

object_name: malignant soft tissue neoplasm


subject: CHEBI:119915

object_name: sarcoma


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: Avian ventriculitis


subject: PUBCHEM.COMPOUND:135582802

object_name: Ventriculitis


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:6801

subject_name: Metformin

object_name: Human Immunodeficiency Virus Positive


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Non ST segment elevation myocardial infarction


subject: UMLS:C3714803

object_name: angina unstable


subject: UMLS:C3714803

object_name: post mi


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:91400

subject_name: Afatinib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: uterine cancer


subject: CHEBI:63660

object_name: inherited lipid metabolism disorder


subject: CHEBI:63660

object_name: Dyslipidemia


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:231681

subject_name: olaratumab

object_name: Plexosarcoma


subject: CHEBI:231681

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Ischemic reperfusion injury


subject: CHEBI:25805

object_name: ST-elevation myocardial infarction


subject: CHEBI:25805

object_name: Non-ST elevation (NSTEMI) myocardial infarction


subject: CHEBI:25805

object_name: acute coronary syndrome


subject: CHEBI:25805


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Delayed Emergence from Anesthesia


subject: UMLS:C0445115

object_name: Hyperventilation


subject: UMLS:C0445115

object_name: hypertension


subject: UMLS:C0445115

object_name: Hypertension, CTCAE


subject: UMLS:C0445115

object_name: Tachycardia by ECG Finding


subject: UMLS:C0445115

object_name: Tachycardia


subject: UMLS:C0445115

object_name: Hypoxemia


subject: UMLS:C0445115

object_name: Hypoxia, CTCAE


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: metastatic melanoma


subject: PR:000001151

object_name: skin neoplasm


subject: PR:000001151

object_name: skin cancer


subject: UMLS:C5206849

subject_name: Anti-PD-1 Monoclonal Antibody BAT1306

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206849

object_name: Adult Solid Neoplasm


subject: UMLS:C5206849

object_name: Solid Neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UMLS:C4082808

subject_name: Advagraf

object_name: Evidence of liver transplantation


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: adenocarcinoma of lung metastatic to brain


subject: UMLS:C5700426

subject_name: furmonertinib


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1258613

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1258613

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1258613

object_name: Renal cell carcinoma recurrent


subject: UMLS:C1258613

object_name: Renal cancer recurrent


subject: UMLS:C0751598

subject_name: Alferon


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: carotid stenosis


subject: PUBCHEM.COMPOUND:6096882

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:6096882

object_name: atherosclerosis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:17579

subject_name: Beta carotene

object_name: vitamin A deficiency


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: UMLS:C4086994

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C4086994

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UMLS:C4086994

object_name: gallbladder cancer


subject: UMLS:C4086994

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UMLS:C4086994

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UMLS:C4086994

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C4086994

object_name: gallbladder carcinoma


subject: UMLS:C4086994

object_name: cholangiocarcinoma


subject: UMLS:C4086994

object_name: biliary tract cancer


subject: UMLS:C4086994

object_name: liver carcinoma


subject: CHEBI:58097

object_name: delirium


subject: CHEBI:58097

object_name: Delirium, CTCAE


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: UMLS:C5783522

subject_name: Anti-HER2 Antibody-drug Conjugate JSKN003

object_name: Childhood Breast Carcinoma


subject: UMLS:C5783522

object_name: breast carcinoma


subject: UMLS:C5783522

object_name: breast cancer


subject: CHEBI:4975

subject_name: Famotidine

object_name: HIV-1 infection


subject: CHEBI:7772

subject_name: omeprazole

object_name: HIV infection


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: kidney neoplasm


subject: UMLS:C1948073


subject: CHEBI:567361

subject_name: Cladribine

object_name: secondary progressive multiple sclerosis


subject: CHEBI:24848

subject_name: inositol

object_name: rectal carcinoma


subject: CHEBI:24848

object_name: rectum adenocarcinoma


subject: CHEBI:24848

object_name: Crohn Disease-Associated Dysplasia of the Colorectum


subject: CHEBI:24848

object_name: Low Grade Dysplasia in Ulcerative Colitis


subject: CHEBI:24848

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:135405876

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:135405876

object_name: schizophrenia 18


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: UMLS:C2929601

subject_name: pyridoxine / vitamin B12


subject: UMLS:C2929601


subject: UMLS:C2929601


subject: CHEMBL.COMPOUND:CHEMBL4297965

object_name: type 2 diabetes mellitus


subject: UNII:2R985002CT

subject_name: Mexidol

object_name: Acute Ischemic Stroke


subject: UMLS:C0128329

subject_name: mexidol


subject: UMLS:C3659483

object_name: Advanced cancer


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:17234

subject_name: D-glucose

object_name: rotator cuff syndrome


subject: CHEBI:17234

object_name: Rotator cuff tear


subject: CHEBI:16348

subject_name: Bovinocidin

object_name: congestive heart failure


subject: CHEBI:16348

object_name: cardiomyopathy


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: CHEBI:80234


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: adrenal cortex carcinoma


subject: UNII:PQX0D8J21J

object_name: adenoid cystic carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0964361

subject_name: SonoVue

object_name: breast neoplasm


subject: CHEBI:30496

subject_name: Sulfur hexafluoride


subject: PUBCHEM.COMPOUND:54751657

subject_name: Minocin

object_name: Acute Kidney Insufficiency


subject: PUBCHEM.COMPOUND:54751657

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:54751657

object_name: Chronic uremia


subject: CHEBI:50697

subject_name: minocycline hydrochloride


subject: CHEBI:50697


subject: CHEBI:50697


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Subacromial bursitis


subject: CHEBI:31932

subject_name: olmesartan

object_name: angina unstable


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:6801

subject_name: Metformin

object_name: habitual spontaneous abortion


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:94449

subject_name: Glycopyrronium

object_name: Hyperhidrosis, CTCAE


subject: CHEBI:94449

object_name: Hyperhidrosis


subject: CHEBI:94449

object_name: Palmar hyperhidrosis


subject: CHEBI:94449

object_name: sweat gland disorder


subject: CHEBI:94449

object_name: skin disorder


subject: CHEBI:50673

subject_name: Methimazole

object_name: adult dermatomyositis


subject: CHEBI:50673

object_name: dermatomyositis


subject: CHEBI:50673

object_name: polymyositis


subject: UNII:0KC57I4UNB

subject_name: Dicycloplatin

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:25185057

subject_name: lefamulin

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:196462

subject_name: ketosteril

object_name: nephrotic syndrome


subject: PUBCHEM.COMPOUND:196462

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C0064327


subject: UMLS:C0064327


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Unresectable Endometrial Carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Melanoma recurrent


subject: UMLS:C0919079

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0919079

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:1805

object_name: prolymphocytic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: UMLS:C2703079

object_name: non-small cell lung carcinoma


subject: CHEBI:6801

object_name: brain cancer


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Complications of Diabetes Mellitus


subject: CHEBI:132774

subject_name: Roxadustat

object_name: diabetic kidney disease


subject: CHEBI:132774


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: CHEBI:49375

subject_name: Dasatinib

object_name: Osteopenia/osteoporosis


subject: CHEBI:49375

object_name: Osteopenia


subject: CHEBI:64073


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Drug Metabolism, Poor, CYP2D6-Related


subject: CHEBI:107736

subject_name: Metoclopramide


subject: UNII:JCU3O35RDS

subject_name: Sonlicromanol

object_name: inborn mitochondrial myopathy


subject: UNII:JCU3O35RDS

object_name: mitochondrial encephalomyopathy


subject: UNII:JCU3O35RDS

object_name: maternally-inherited diabetes and deafness


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: CHEBI:63607

subject_name: Linezolid

object_name: bacterial infectious disease


subject: CHEBI:140427

subject_name: Desirudin

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:140427

object_name: Deep venous thrombosis


subject: UMLS:C0109207


subject: UMLS:C0109207


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: Burn shock


subject: UMLS:C3813201

object_name: Burn and corrosion, body region unspecified


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C0078516


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: UMLS:C1443923


subject: UMLS:C0591531

subject_name: forceval

object_name: heart failure


subject: UMLS:C0591531

object_name: Heart Failure, CTCAE


subject: UMLS:C3896755

subject_name: Gamboge Resin Extract TSB-9-W1

object_name: metastatic colorectal cancer


subject: DRUGBANK:DB14277

subject_name: Tripterygium wilfordii whole

object_name: lupus nephritis


subject: UMLS:C1951628

subject_name: RepHresh

object_name: bacterial vaginosis


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Metastatic Gastric Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic malignant neoplasm to peritoneum


subject: UNII:M89N0Q7EQR

object_name: gastric adenocarcinoma


subject: UNII:M89N0Q7EQR


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: long COVID-19


subject: UNII:73SM5SF3OR

object_name: Fatigue


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE

object_name: metastatic prostate carcinoma


subject: CHEBI:73508

subject_name: Glu-Pro

object_name: Small cell lung cancer extensive stage


subject: PR:000006295

subject_name: acyl-CoA-binding protein


subject: PR:000008736

subject_name: BLOC-3 complex member HPS1


subject: CHEBI:15365

subject_name: Aspirin

object_name: Drug action increased


subject: CHEBI:34674

subject_name: dextran sulfate

object_name: HIV infection


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: Diabetes


subject: CHEBI:71196

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: UMLS:C4548896

object_name: Hepatic impairment


subject: UNII:JJX4JHS4PO

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C2346687


subject: GTOPDB:8221

subject_name: epacadostat


subject: UNII:2HR315841W


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: interstitial cystitis


subject: UMLS:C4287766

object_name: HER2-positive gastric cancer


subject: DRUGBANK:DB16994

object_name: myasthenia gravis


subject: DRUGBANK:DB16994

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Acute appendicitis NOS (disorder)


subject: UMLS:C0591774

subject_name: meronem

object_name: appendicitis


subject: UMLS:C0591774


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:50687

subject_name: metronidazole hydrochloride


subject: CHEBI:50687


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Convulsive status epilepticus


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:3756

subject_name: Clonazepam


subject: GTOPDB:10492

subject_name: envafolimab

object_name: intrahepatic cholangiocarcinoma


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: PUBCHEM.COMPOUND:2198

object_name: metastatic colorectal cancer


subject: UNII:01343Q8EL8

subject_name: Anisodamine


subject: CHEBI:7627

subject_name: Norethisterone

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:7627

object_name: primary progressive multiple sclerosis


subject: CHEBI:87620

subject_name: EPIESTRIOL


subject: CHEBI:87620


subject: CHEBI:27974

subject_name: Estriol


subject: CHEBI:27974


subject: UMLS:C5814355

object_name: hemophilia A


subject: UMLS:C5814355

object_name: hemophilia B


subject: UMLS:C5814355

object_name: hemophilia B leyden


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: macular degeneration


subject: CHEBI:25681

object_name: age-related macular degeneration


subject: CHEBI:25681

object_name: retinitis pigmentosa 30


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C0982273

subject_name: MENINGOCOCCAL POLYSACCHARIDE

object_name: Invasive meningococcal disease


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: morbid obesity


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Physical stress


subject: CHEBI:3215

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:3215

object_name: Back pain


subject: CHEBI:3215

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:3215

object_name: Surgery--Complications


subject: UMLS:C3491977

object_name: hepatitis C


subject: UNII:8V42Y78HRU


subject: UMLS:C3491774


subject: CHEMBL.COMPOUND:CHEMBL4594322

subject_name: EFTOZANERMIN ALFA

object_name: plasma cell myeloma


subject: UMLS:C4687510


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: alopecia


subject: CHEBI:17650

object_name: hypotrichosis


subject: PR:000004904

subject_name: complement C5


subject: PR:000004904


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Sedation complication


subject: UMLS:C4305786

object_name: kidney disorder


subject: UMLS:C4305786

object_name: kidney failure


subject: CHEBI:231614

subject_name: Nivolumab

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C2346820


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: UMLS:C0591904


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:177769

subject_name: Sovaprevir


subject: CHEBI:233453

object_name: Neonatal Herpes Simplex Infection


subject: CHEBI:35854

subject_name: Valaciclovir


subject: MESH:C000720499

subject_name: GX-19N vaccine


subject: CHEBI:29947

subject_name: glycine residue

object_name: mild neurocognitive disorder


subject: CHEBI:29947

object_name: mild cognitive impairment


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: UNII:W6F4FRQ5QC

subject_name: PULRODEMSTAT

object_name: myeloid leukemia


subject: UMLS:C4330526


subject: CHEBI:63043

object_name: toothache


subject: UNII:LPU25F15UQ

subject_name: Azeliragon

object_name: High grade glioma


subject: UNII:LPU25F15UQ

object_name: malignant glioma


subject: UNII:LPU25F15UQ

object_name: neoplastic meningitis


subject: UNII:LPU25F15UQ

object_name: Childhood Solid Neoplasm


subject: UNII:LPU25F15UQ

object_name: Adult Solid Neoplasm


subject: UNII:LPU25F15UQ

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Obesity, Metabolically Benign


subject: PUBCHEM.COMPOUND:18772499

object_name: metabolically healthy obesity


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: tic disorder


subject: CHEBI:51254

object_name: Compulsion


subject: CHEBI:51254

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:51254

object_name: Autoimmunity


subject: CHEBI:51254

object_name: psychosis


subject: CHEBI:51254

object_name: mental disorder


subject: CHEBI:51254

object_name: psychiatric disorder


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Amyloid deposition


subject: CHEBI:229764

subject_name: Selinexor

object_name: AL amyloidosis


subject: CHEBI:229764

object_name: amyloidosis


subject: CHEBI:229764


subject: UMLS:C5418041

subject_name: FGFR Inhibitor CPL304110

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5418041

object_name: endometrial cancer


subject: UMLS:C5418041

object_name: uterine corpus cancer


subject: UMLS:C5418041

object_name: endometrial carcinoma


subject: UMLS:C5418041

object_name: cholangiocarcinoma


subject: UMLS:C5418041

object_name: Stomach cancer


subject: UMLS:C5418041

object_name: gastric cancer


subject: UMLS:C5418041

object_name: bladder tumor


subject: UMLS:C5418041

object_name: urinary bladder carcinoma


subject: UMLS:C5418041

object_name: urinary bladder cancer


subject: UMLS:C5418041

object_name: childhood bladder carcinoma


subject: UMLS:C5418041

object_name: malignant soft tissue neoplasm


subject: UMLS:C5418041

object_name: sarcoma


subject: CHEBI:50730

subject_name: Montelukast

object_name: dizziness


subject: CHEBI:50730

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:50730

object_name: Vertigo, CTCAE


subject: CHEBI:50730

object_name: Meniere disease


subject: CHEBI:52010

subject_name: chlorphenamine

object_name: Voice disorder due to iatrogenic factor


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Dyspnea


subject: CHEBI:16480

object_name: Dyspnea, CTCAE


subject: CHEBI:16480

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Heart Decompensation


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage II Bladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: bladder transitional cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:232556

subject_name: Erdafitinib


subject: CHEBI:232556


subject: CHEBI:232556

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:232556


subject: CHEBI:232556


subject: CHEBI:232556

object_name: transitional cell carcinoma


subject: CHEBI:232556


subject: CHEBI:232556

object_name: urothelial carcinoma


subject: CHEBI:6504

object_name: Childhood Solid Neoplasm


subject: CHEBI:6504

object_name: Adult Solid Neoplasm


subject: CHEBI:6504

object_name: Solid Neoplasm


subject: CHEBI:6504

object_name: cognitive/functional effects


subject: CHEBI:6504

object_name: neurotoxicity


subject: CHEBI:28838

subject_name: Lutein

object_name: glaucoma


subject: CHEBI:28838

object_name: Glaucoma, CTCAE


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: CHEBI:27547


subject: CHEBI:138919

subject_name: meso-zeaxanthin


subject: CHEBI:138919


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: childhood apraxia of speech


subject: CHEBI:16347

object_name: Speech apraxia


subject: CHEBI:16347

object_name: pervasive developmental disorder


subject: CHEBI:16347

object_name: autism


subject: UMLS:C3899465

subject_name: ADC DLYE5953A

object_name: neoplasm


subject: CHEBI:9014

subject_name: Salsalate

object_name: preeclampsia


subject: UMLS:C2976746

subject_name: SAB 378

object_name: polyneuropathy


subject: PUBCHEM.COMPOUND:34698

subject_name: Teniposide

object_name: primary central nervous system lymphoma


subject: UMLS:C5667101

subject_name: HER2/neu Peptide Vaccine GLSI-100

object_name: Childhood Breast Carcinoma


subject: UMLS:C5667101

object_name: breast carcinoma


subject: UMLS:C5667101

object_name: breast cancer


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Acute gastroenteritis


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: carcinoma of esophagus


subject: GTOPDB:9592

object_name: Childhood Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:TK694ZFS57

object_name: adrenogenital syndrome


subject: UNII:TK694ZFS57

object_name: congenital adrenal hyperplasia


subject: UMLS:C5418476

subject_name: Nevanimibe Hydrochloride


subject: UMLS:C5418476


subject: UMLS:C5418013

subject_name: SOD Mimetic GC4711

object_name: non-small cell lung carcinoma


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Tourette syndrome


subject: CHEBI:193615

object_name: Recurrent Rectal Cancer


subject: CHEBI:193615

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:193615

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:193615

object_name: Rectal cancer stage IV


subject: CHEBI:193615

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:193615

object_name: Colon cancer recurrent


subject: CHEBI:193615

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:193615

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:193615

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:193615

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: glycogen storage disease I


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:28061

subject_name: galactose


subject: CHEBI:42905

subject_name: L-Galactose


subject: KEGG.COMPOUND:C01582

subject_name: Galactose


subject: UNII:87TZD0JEBS

object_name: myelofibrosis


subject: UNII:87TZD0JEBS

object_name: myeloproliferative neoplasm


subject: UNII:87TZD0JEBS

object_name: Malignant myeloproliferative neoplasm


subject: UNII:87TZD0JEBS

object_name: Myelodysplasia


subject: UNII:87TZD0JEBS

object_name: Adult Myelodysplastic Syndrome


subject: UNII:87TZD0JEBS

object_name: childhood myelodysplastic syndrome


subject: UNII:87TZD0JEBS

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:87TZD0JEBS

object_name: essential thrombocythemia


subject: UMLS:C0030956

subject_name: Peptides

object_name: carcinoma of esophagus


subject: UMLS:C0030956

object_name: esophageal cancer


subject: UMLS:C0030956

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0030956

object_name: neoplasm of esophagus


subject: PR:000018264

subject_name: proteolytic cleavage product


subject: PR:000018264


subject: PR:000018264


subject: PR:000018264


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: tonsillitis


subject: PUBCHEM.COMPOUND:2171


subject: UMLS:C0740072

subject_name: Penamox


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C4521010

subject_name: AutoSynVax Vaccine

object_name: Advanced cancer


subject: CHEBI:47781

subject_name: Desipramine

object_name: cancer


subject: CHEBI:47781

object_name: neoplasm


subject: CHEBI:124917

subject_name: Rabusertib


subject: CHEBI:124917


subject: UMLS:C2987370

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2987370

object_name: stage IV pancreatic cancer


subject: UMLS:C2987370

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C0007507

subject_name: Antigens, CD25


subject: UMLS:C0007507

object_name: graft versus host disease


subject: UMLS:C0007507

object_name: adult lymphoma


subject: UMLS:C0007507

object_name: lymphoma


subject: UMLS:C0007507

object_name: pediatric lymphoma


subject: UMLS:C0007507

object_name: leukemia


subject: UMLS:C0007507

object_name: childhood leukemia


subject: PR:000001380

subject_name: interleukin-2 receptor subunit alpha

object_name: Myelodysplasia


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: CHEBI:84040

object_name: neuroendocrine neoplasm


subject: CHEBI:84040

object_name: APUdoma


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: B-cell lymphoma refractory


subject: UNII:D6OMY2L0WA

object_name: B-cell lymphoma recurrent


subject: UNII:D6OMY2L0WA

object_name: Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: fetal and neonatal alloimmune thrombocytopenia


subject: UMLS:C0085297

object_name: neonatal thrombocytopenia


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:45783

subject_name: Imatinib

object_name: lymphoblastic lymphoma


subject: CHEBI:45783

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: Childhood Lymphoblastic Lymphoma


subject: UNII:V0Q46LFE6F

object_name: acute myeloid leukemia by FAB classification


subject: UNII:V0Q46LFE6F

object_name: acute myeloid leukemia


subject: UMLS:C5784725

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5784725

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:126664

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:126664

object_name: coronary atherosclerosis


subject: CHEBI:231614

subject_name: Nivolumab

object_name: High grade serous carcinoma


subject: UMLS:C2346820


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689

object_name: endometrioid adenocarcinoma


subject: CHEBI:134689

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:134689

object_name: peritoneal carcinoma


subject: UMLS:C2986399

object_name: HER2 positive breast carcinoma


subject: UMLS:C2986399

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2986399

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2986399

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2986399

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Accelerated Phase of Disease


subject: PUBCHEM.COMPOUND:1805

object_name: Blastic Phase


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:94531

subject_name: belinostat


subject: CHEBI:94531

object_name: Recurrent disease


subject: CHEBI:94531


subject: CHEBI:94531

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:94531

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:94531

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:94531


subject: CHEBI:94531

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:94531

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:94531

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:94531


subject: CHEBI:94531

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:94531

object_name: chronic myelomonocytic leukemia


subject: CHEBI:94531

object_name: myelofibrosis


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: diabetic polyneuropathy


subject: MESH:C421011

object_name: neoplasm


subject: UMLS:C3896757

subject_name: TGFBR1 Inhibitor TEW-7197

object_name: Stomach cancer


subject: UMLS:C3896757

object_name: gastric cancer


subject: UMLS:C3896757


subject: UMLS:C3896757

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: carpal tunnel syndrome 1


subject: PUBCHEM.COMPOUND:521372

object_name: carpal tunnel syndrome


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: Paediatric hypertension


subject: CHEMBL.COMPOUND:CHEMBL5314814

subject_name: BUDOPRUTUG


subject: UMLS:C5908921

subject_name: Budoprutug


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: osteoarthritis


subject: UMLS:C4733649

subject_name: Anti-CD20 Monoclonal Antibody B001

object_name: neuromyelitis optica


subject: CHEBI:42797

subject_name: Gabapentin

object_name: herpetic neuralgia


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: hepatitis C


subject: RXCUI:8375

object_name: chronic hepatitis C virus infection


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Chemotherapy-induced nausea and vomiting


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: small cell lung carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: EXCESS LMW-DNA


subject: CHEBI:70752

subject_name: Dabigatran

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: schizoaffective disorder


subject: CHEBI:127342

object_name: schizophrenia 18


subject: UNII:IJ34D6YPAO

subject_name: Polmacoxib

object_name: osteoarthritis, hip


subject: UNII:IJ34D6YPAO

object_name: osteoarthritis, knee


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: IMMUNE SUPPRESSION


subject: CHEBI:40968

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:40968

object_name: Inflammatory Response


subject: CHEBI:40968

object_name: metabolic disturbance


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: acute lymphoblastic leukemia


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C5425888

subject_name: Inhaled iloprost

object_name: Chronic left ventricular failure


subject: UMLS:C4305969

object_name: lower urinary tract symptom


subject: CHEBI:8499

subject_name: Propranolol

object_name: social phobia


subject: UniProtKB:P0A9E0

subject_name: ARAC_ECOLI Arabinose operon regulatory protein (sprot)

object_name: acute myeloid leukemia by FAB classification


subject: UniProtKB:P0A9E0

object_name: acute myeloid leukemia


subject: CHEBI:6801

subject_name: Metformin

object_name: cervical cancer


subject: CHEBI:6801

object_name: cervical carcinoma


subject: UMLS:C5815535

object_name: Duchenne muscular dystrophy


subject: CHEBI:4672

object_name: Neoplasm Recurrence, Local


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: fibromyalgia


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: spastic diplegia


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C0939246

subject_name: Advair Diskus

object_name: Depressed mood


subject: UMLS:C0939246

object_name: Cancer patients and suicide and depression


subject: UMLS:C0939246

object_name: Depressed - symptom


subject: UMLS:C0939246

object_name: Depression, CTCAE


subject: UMLS:C0939246

object_name: chronic obstructive pulmonary disease


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Malignant Solid Neoplasm


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: PUBCHEM.COMPOUND:2269

object_name: infectious otitis media


subject: PUBCHEM.COMPOUND:2269

object_name: Acute otitis media


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents

object_name: Ventricular arrhythmia


subject: UMLS:C1979623

subject_name: Antiarrythmic drugs


subject: CHEBI:567361

subject_name: Cladribine

object_name: childhood acute myeloid leukemia


subject: GTOPDB:4934

subject_name: G-CSF

object_name: acute monocytic leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IA Uterine Sarcoma AJCC v7


subject: CHEBI:4672

object_name: Stage IC Uterine Sarcoma AJCC v7


subject: CHEBI:4672

object_name: Stage IB Uterine Sarcoma AJCC v7


subject: CHEBI:4672

object_name: sarcoma of uterus stage IIa


subject: CHEBI:4672

object_name: Stage IIA Uterine Sarcoma AJCC v7


subject: CHEBI:4672

object_name: sarcoma of uterus stage IIb


subject: CHEBI:4672

object_name: Stage IIB Uterine Sarcoma AJCC v7


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: lip and oral cavity carcinoma


subject: UNII:5S371K6132

object_name: oral cavity cancer


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: hepatitis C


subject: CHEBI:90942

subject_name: Ixazomib

object_name: chronic graft versus host disease


subject: UMLS:C4085989

subject_name: ADC ABBV-085

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4085989

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C4085989

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UMLS:C4085989

object_name: female breast carcinoma


subject: UMLS:C4085989

object_name: male breast carcinoma


subject: UMLS:C4085989

object_name: breast carcinoma


subject: UMLS:C2717562

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C5447414

subject_name: JAK2 Inhibitor TQ05105

object_name: hemophagocytic syndrome


subject: CHEBI:74528

subject_name: Leu-D-Leu

object_name: colorectal cancer


subject: CHEBI:191208

subject_name: Leu-Leu


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Myelodysplasia


subject: CHEBI:231679

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:231679

object_name: childhood myelodysplastic syndrome


subject: CHEBI:231679

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:231614

subject_name: Nivolumab

object_name: leukemia


subject: CHEBI:231614

object_name: childhood leukemia


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:50733

subject_name: nutraceutical

object_name: chronic pain (diagnosis)


subject: CHEBI:50733

object_name: Chronic pain


subject: CHEBI:50733

object_name: Inflammatory Response


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Indolent lymphoma


subject: CHEBI:567361

subject_name: Cladribine


subject: CHEBI:567361


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: skin melanoma


subject: UMLS:C3827149


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:77733

subject_name: Verapamil


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:90227

subject_name: Selumetinib

object_name: rectal carcinoma


subject: CHEBI:90227

object_name: rectal cancer


subject: CHEBI:90227

object_name: Childhood Rectal Carcinoma


subject: CHEBI:94782

subject_name: Cediranib


subject: CHEBI:94782


subject: CHEBI:94782


subject: UMLS:C1541530


subject: UMLS:C1541530


subject: UMLS:C1541530


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: spondyloarthropathy


subject: CHEBI:7903

object_name: vertebral joint disorder


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: UNII:WP58SVM6R4

subject_name: Laronidase

object_name: mucopolysaccharidosis I, domestic cat


subject: UNII:WP58SVM6R4

object_name: mucopolysaccharidosis I, dog


subject: CHEBI:40237

subject_name: Sitagliptin

object_name: Insulin resistance


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:85078

object_name: Hyperglycemia, CTCAE


subject: CHEBI:85078

object_name: Glucose in blood specimen above reference range


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Recurrent Uveal Melanoma


subject: CHEBI:72317

object_name: Stage III Uveal Melanoma AJCC v7


subject: CHEBI:72317

object_name: Stage IV Uveal Melanoma AJCC v7


subject: CHEBI:72317

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: CHEBI:72317

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: CHEBI:72317

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:4305


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:73179

subject_name: 2,6-dichloroisonicotinic acid


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: Neoplasm of uncertain or unknown behavior of kidney


subject: UMLS:C4721945

object_name: kidney benign neoplasm


subject: UMLS:C4721945

object_name: Kidney problem


subject: CHEBI:63660

object_name: ventilator-associated pneumonia


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: carcinoid tumor


subject: UNII:15C2VL427D

object_name: neuroendocrine neoplasm


subject: UNII:15C2VL427D

object_name: digestive system neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: anxiety


subject: PUBCHEM.COMPOUND:521372

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:521372

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:521372

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:521372

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN

object_name: Parkinson disease


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:53762


subject: CHEBI:32315

subject_name: Zopiclone


subject: GTOPDB:13484

subject_name: palopegteriparatide

object_name: parathyroid gland disorder


subject: GTOPDB:13484

object_name: endocrine system disorder


subject: UNII:G2N64C3385

subject_name: PALOPEGTERIPARATIDE


subject: UNII:G2N64C3385


subject: PUBCHEM.COMPOUND:108169

subject_name: Taxane

object_name: HER2-positive gastric cancer


subject: PUBCHEM.COMPOUND:108169

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:108169

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:108169

object_name: Neoplasm Metastasis


subject: UMLS:C0796419

subject_name: Taxanes


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: CHEBI:165874

object_name: Recurrent ovarian cancer


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:192614

object_name: COPD, severe early onset


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: cervical adenocarcinoma


subject: CHEBI:233362

object_name: adenocarcinoma


subject: CHEBI:233362

object_name: bile duct adenocarcinoma


subject: CHEBI:233362

object_name: gastric adenocarcinoma


subject: CHEBI:233362

object_name: gastroesophageal cancer


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: localized Castleman disease


subject: UNII:4F4X42SYQ6

object_name: Castleman disease


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: myelofibrosis


subject: UMLS:C1872504

object_name: asthma


subject: UMLS:C5392734

object_name: bacterial infectious disease


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Thyroid associated orbitopathy


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Locally Advanced Gastric Carcinoma


subject: CHEBI:77572

subject_name: Tranilast

object_name: pterygium


subject: CHEBI:77572

object_name: conjunctival pterygium


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: neuroendocrine carcinoma


subject: MESH:D000077324

subject_name: Crystalloid Solutions

object_name: pathologic hemodilution


subject: UMLS:C0056562

subject_name: crystalloid solutions


subject: UMLS:C5237229

subject_name: Neoantigen Peptide Vaccine

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C5237229

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: UMLS:C5237229

object_name: Recurrent Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C5237229

object_name: Recurrent HER2-Negative Breast Carcinoma


subject: UMLS:C5237229

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C5237229

object_name: Metastatic Mucosal Melanoma


subject: UMLS:C5237229

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C5237229

object_name: Metastatic Conjunctival Melanoma


subject: UMLS:C5237229

object_name: Recurrent Mucosal Melanoma


subject: UMLS:C5237229

object_name: Melanoma recurrent


subject: UMLS:C5237229

object_name: Unresectable Acral Lentiginous Melanoma


subject: UMLS:C5237229

object_name: Locally Advanced Mucosal Melanoma


subject: UMLS:C5237229

object_name: Unresectable Mucosal Melanoma


subject: UMLS:C5237229

object_name: Unresectable Cutaneous Melanoma


subject: UMLS:C5237229

object_name: Locally Advanced Cutaneous Melanoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: Stage III Lung Cancer AJCC v8


subject: DRUGBANK:DB17293

object_name: Stage IV Lung Cancer AJCC v8


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293

object_name: Metastatic Malignant Solid Neoplasm


subject: DRUGBANK:DB17293

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: DRUGBANK:DB17293

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: DRUGBANK:DB17293

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Recurrent Hormone Receptor-Positive Breast Carcinoma


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70

object_name: Recurrent HER2-Negative Breast Carcinoma


subject: UNII:7KYP9TKT70

object_name: Non-small cell lung cancer recurrent


subject: UNII:7KYP9TKT70

object_name: Metastatic Mucosal Melanoma


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70

object_name: Metastatic Cutaneous Melanoma


subject: UNII:7KYP9TKT70

object_name: Metastatic Conjunctival Melanoma


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70

object_name: Recurrent Mucosal Melanoma


subject: UNII:7KYP9TKT70

object_name: Melanoma recurrent


subject: UNII:7KYP9TKT70

object_name: Unresectable Acral Lentiginous Melanoma


subject: UNII:7KYP9TKT70

object_name: Locally Advanced Mucosal Melanoma


subject: UNII:7KYP9TKT70

object_name: Unresectable Mucosal Melanoma


subject: UNII:7KYP9TKT70

object_name: Unresectable Cutaneous Melanoma


subject: UNII:7KYP9TKT70

object_name: Locally Advanced Cutaneous Melanoma


subject: CHEBI:231614

object_name: Malignant pleural effusion


subject: UMLS:C2346820


subject: MESH:C000629782

subject_name: talimogene laherparepvec


subject: MESH:C000629782

object_name: lung cancer


subject: MESH:C000629782

object_name: lung neoplasm


subject: MESH:C000629782

object_name: lung carcinoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Prostate cancer recurrent


subject: UMLS:C0529515

object_name: spinal cord injury


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:25805

subject_name: oxygen atom

object_name: postpartum hemorrhage


subject: CHEBI:25805

object_name: Post-partum hemorrhage


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: acute myocardial infarction


subject: UMLS:C1527137

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: UMLS:C0539859

object_name: Hyponatremia


subject: UMLS:C0539859

object_name: Hyponatremia, CTCAE


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Papulopustular Rosacea


subject: CHEBI:17549

object_name: rosacea


subject: CHEBI:8378

subject_name: Prednisolone

object_name: respiratory tract infectious disorder


subject: CHEBI:17630

subject_name: Kanamycin

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:4456137

object_name: Colon Neoplasm


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: DRUGBANK:DB14276

subject_name: Turmeric

object_name: psoriasis


subject: GTOPDB:10492

subject_name: envafolimab

object_name: metastatic colorectal cancer


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: CHEBI:144094

subject_name: bicalutamide

object_name: gynecomastia


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: plasmacytoid variant infiltrating bladder urothelial carcinoma


subject: UNII:KXG2PJ551I

object_name: infiltrating bladder urothelial carcinoma sarcomatoid variant


subject: UNII:KXG2PJ551I

object_name: Invasive Bladder Urothelial Carcinoma with Squamous Differentiation


subject: UNII:KXG2PJ551I

object_name: Invasive Bladder Urothelial Carcinoma with Glandular Differentiation


subject: UNII:KXG2PJ551I

object_name: micropapillary variant infiltrating bladder urothelial carcinoma


subject: UNII:KXG2PJ551I

object_name: MTAP Negative


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724

object_name: Metastatic urothelial carcinoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C5962496

subject_name: Anti-ULBP6 Monoclonal Antibody 23ME-01473

object_name: Childhood Solid Neoplasm


subject: UMLS:C5962496

object_name: Adult Solid Neoplasm


subject: UMLS:C5962496

object_name: Solid Neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hip arthropathy


subject: UMLS:C2698156

object_name: Childhood Breast Carcinoma


subject: UMLS:C2698156

object_name: breast carcinoma


subject: UMLS:C2698156

object_name: breast cancer


subject: CHEBI:134722

subject_name: Favipiravir

object_name: Ebola hemorrhagic fever


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Pelvis fracture


subject: CHEBI:39548

object_name: Hip Fracture, CTCAE


subject: CHEBI:39548

object_name: hip fracture


subject: UNII:AD0O8X2QJR

subject_name: Ubrogepant

object_name: Migraine with or without aura


subject: PUBCHEM.COMPOUND:10458325

subject_name: tesevatinib

object_name: Recurrent Childhood Glioblastoma